Background Treatment of multiple sclerosis with natalizumab is complicated by rare
occurrence of progressive multifocal leukoencephalopathy (PML). Between July, 2006, and …

… (D) Immunostaining with polyclonal antibody to JC virus from Abcam Inc. shows dark brown
staining of nuclei of several oligodendrocytes. (E) Electron micrograph of crystalline array of …

Neurological involvement in HIV is often associated with cognitive impairment. Although
severe and progressive neurocognitive impairment has become rare in HIV clinics in the era of …

… ’d her Body should be carried away & not interr’d at Skipton; so as I took that as a sign that
I should be dispossessed of the Inheritance of my Forefathers. The same night I sent Hamon …

… Clifford serves/has served on scientific advisory boards for Biogen Idec, Elan Corporation,
Roche, Forest Laboratories, Inc., Genentech, Inc., GlaxoSmithKline, Millennium …

In 1991, the AIDS Task Force of the American Academy of Neurology published nomenclature
and research case definitions to guide the diagnosis of neurologic manifestations of HIV-1 …

Combination antiretroviral therapy (CART) has greatly reduced medical morbidity and
mortality with HIV infection, but high rates of HIV-associated neurocognitive disorders (HAND) …

… Dr Clifford has served as a consultant for Biogen Idec, Genzyme, Millennium Pharmaceuticals,
Schering-Plough, Roche, Elan, Novartis, and Genentech and as a speaker for Boehringer-…

Background Progressive multifocal leukoencephalopathy (PML) was reported to have
developed in three patients treated with natalizumab. We conducted an evaluation to determine …

Objectives: Efavirenz is an effective antiretroviral agent, but central nervous system side
effects occur commonly, and population (racial) differences in pharmacokinetics and response …